• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Splenic Stiffness Measurement Combined With Liver Stiffness Measurement Compared With Baveno VII Criteria in Predicting the Presence of Oesophageal and Gastric Varices in Patients With Compensated Advanced Liver Cell Disease (cALCD).在代偿期晚期肝细胞疾病(cALCD)患者中,脾硬度测量联合肝硬度测量与Baveno VII标准在预测食管和胃静脉曲张存在方面的比较
Cureus. 2024 Aug 1;16(8):e65954. doi: 10.7759/cureus.65954. eCollection 2024 Aug.
2
Accuracy of spleen stiffness measurement for the diagnosis of clinically significant portal hypertension in patients with compensated advanced chronic liver disease: a systematic review and individual patient data meta-analysis.脾脏硬度测量对代偿期晚期慢性肝病患者临床显著性门静脉高压诊断的准确性:一项系统评价和个体患者数据荟萃分析
Lancet Gastroenterol Hepatol. 2023 Sep;8(9):816-828. doi: 10.1016/S2468-1253(23)00150-4. Epub 2023 Jul 18.
3
A combined model based on spleen stiffness measurement and Baveno VI criteria to rule out high-risk varices in advanced chronic liver disease.基于脾脏硬度测量和 Baveno VI 标准的联合模型排除晚期慢性肝病高危静脉曲张。
J Hepatol. 2018 Aug;69(2):308-317. doi: 10.1016/j.jhep.2018.04.023. Epub 2018 May 3.
4
Spleen stiffness measurement predicts decompensation and rules out high-risk oesophageal varices in primary biliary cholangitis.脾脏硬度测量可预测原发性胆汁性胆管炎的失代偿,并排除高风险食管静脉曲张。
JHEP Rep. 2023 Oct 31;6(1):100952. doi: 10.1016/j.jhepr.2023.100952. eCollection 2024 Jan.
5
Validation of Baveno VII criteria and other non-invasive diagnostic algorithms for clinically significant portal hypertension in hepatitis delta.验证 Baveno VII 标准和其他非侵入性诊断算法在乙型肝炎 delta 中对临床显著门脉高压的诊断价值。
J Hepatol. 2024 Aug;81(2):248-257. doi: 10.1016/j.jhep.2024.03.005. Epub 2024 Mar 11.
6
Baveno VII algorithm outperformed other models in ruling out high-risk varices in individuals with HBV-related cirrhosis.巴韦诺 VII 算法在排除乙肝相关肝硬化患者的高风险静脉曲张方面比其他模型表现更优。
J Hepatol. 2023 Mar;78(3):574-583. doi: 10.1016/j.jhep.2022.10.030. Epub 2022 Nov 7.
7
Performance of spleen stiffness measurement by 100-Hz vibration-controlled transient elastography, liver stiffness, APRI score and their combination for predicting oesophageal varices in liver cirrhosis.100Hz 振动控制瞬时弹性成像技术测量脾脏硬度、肝硬度、APRI 评分及其联合预测肝硬化食管静脉曲张的性能。
Clin Res Hepatol Gastroenterol. 2024 Oct;48(8):102456. doi: 10.1016/j.clinre.2024.102456. Epub 2024 Sep 1.
8
Validation of the Baveno VI criteria to identify low risk cirrhotic patients not requiring endoscopic surveillance for varices.验证 Baveno VI 标准以识别低风险肝硬化患者,这些患者无需进行静脉曲张内镜监测。
J Hepatol. 2016 Nov;65(5):899-905. doi: 10.1016/j.jhep.2016.06.021. Epub 2016 Jul 5.
9
Non-invasive prediction of esophageal varices by stiffness and platelet in non-alcoholic fatty liver disease cirrhosis.非酒精性脂肪性肝病肝硬化通过硬度和血小板对食管静脉曲张的无创预测。
J Hepatol. 2018 Oct;69(4):878-885. doi: 10.1016/j.jhep.2018.05.019. Epub 2018 May 24.
10
A novel spleen-dedicated stiffness measurement by FibroScan® improves the screening of high-risk oesophageal varices.FibroScan® 新型脾脏硬度测量可改善高危食管静脉曲张的筛查。
Liver Int. 2020 Jan;40(1):175-185. doi: 10.1111/liv.14228. Epub 2019 Sep 11.

本文引用的文献

1
Letter to editor 'Non-invasive model for predicting high-risk esophageal varices based on liver and spleen stiffness'.致编辑的信:“基于肝脏和脾脏硬度预测高危食管静脉曲张的非侵入性模型”
World J Hepatol. 2023 Nov 27;15(11):1250-1252. doi: 10.4254/wjh.v15.i11.1250.
2
Predictive value of liver and spleen stiffness measurement based on two-dimensional shear wave elastography for the portal vein pressure in patients with compensatory viral cirrhosis.二维剪切波弹性成像测量肝脾硬度对代偿性病毒性肝硬化患者门静脉压力的预测价值。
PeerJ. 2023 Sep 15;11:e15956. doi: 10.7717/peerj.15956. eCollection 2023.
3
Non-invasive model for predicting high-risk esophageal varices based on liver and spleen stiffness.基于肝脾硬度的预测高危食管静脉曲张的无创模型。
World J Gastroenterol. 2023 Jul 7;29(25):4072-4084. doi: 10.3748/wjg.v29.i25.4072.
4
Baveno VI and VII criteria are not suitable for screening for large varices or clinically significant portal hypertension in patients with hepatocellular carcinoma.Baveno VI 和 VII 标准不适用于筛查肝细胞癌患者的大静脉曲张或临床显著门静脉高压。
Aliment Pharmacol Ther. 2023 Aug;58(3):346-356. doi: 10.1111/apt.17599. Epub 2023 Jun 9.
5
Baveno VII Criteria Is an Accurate Risk Stratification Tool to Predict High-Risk Varices Requiring Intervention and Hepatic Events in Patients with Advanced Hepatocellular Carcinoma.巴韦诺 VII 标准是一种准确的风险分层工具,可用于预测晚期肝细胞癌患者中需要干预的高危静脉曲张和肝脏事件。
Cancers (Basel). 2023 Apr 26;15(9):2480. doi: 10.3390/cancers15092480.
6
A Combined Baveno VII and Spleen Stiffness Algorithm to Improve the Noninvasive Diagnosis of Clinically Significant Portal Hypertension in Patients With Compensated Advanced Chronic Liver Disease.一种联合 Baveno VII 和脾脏硬度算法,以改善代偿期慢性肝病患者临床显著门静脉高压的无创诊断。
Am J Gastroenterol. 2022 Nov 1;117(11):1825-1833. doi: 10.14309/ajg.0000000000001887. Epub 2022 Jul 21.
7
Non-invasive evaluation of NAFLD and the contribution of genes: an MRI-PDFF-based cross-sectional study.基于 MRI-PDFF 的非酒精性脂肪性肝病无创评估及基因作用:一项横断面研究。
Hepatol Int. 2022 Oct;16(5):1035-1051. doi: 10.1007/s12072-022-10355-2. Epub 2022 Jul 12.
8
Baveno VII - Renewing consensus in portal hypertension.《巴韦诺 VII 共识:门静脉高压领域的新共识》
J Hepatol. 2022 Apr;76(4):959-974. doi: 10.1016/j.jhep.2021.12.022. Epub 2021 Dec 30.
9
Using MR elastography to assess portal hypertension and response to beta-blockers in patients with cirrhosis.使用磁共振弹性成像评估肝硬化患者的门静脉高压及对β受体阻滞剂的反应。
Liver Int. 2021 Sep;41(9):2149-2158. doi: 10.1111/liv.14981. Epub 2021 Jun 16.
10
Spleen Stiffness as Predictor of Esophageal Varices in Cirrhosis of Different Etiologies.脾脏硬度作为不同病因肝硬化食管静脉曲张的预测因子。
Sci Rep. 2019 Nov 7;9(1):16190. doi: 10.1038/s41598-019-52407-y.

在代偿期晚期肝细胞疾病(cALCD)患者中,脾硬度测量联合肝硬度测量与Baveno VII标准在预测食管和胃静脉曲张存在方面的比较

Splenic Stiffness Measurement Combined With Liver Stiffness Measurement Compared With Baveno VII Criteria in Predicting the Presence of Oesophageal and Gastric Varices in Patients With Compensated Advanced Liver Cell Disease (cALCD).

作者信息

de Silva Arjuna P, Niriella Madunil A, Nishad Nilanga, Jayasundara Hishali, Jayasena Hiruni, Samarawickrama Vajira T, Ranawaka Chamila, Basnayake Kumarini, de Silva Shamila T, de Silva Hithanadura J

机构信息

Department of Medicine, University Medical Unit, Colombo North Teaching Hospital, Faculty of Medicine, University of Kelaniya, Ragama, LKA.

Gastroenterology and Hepatology, Addenbrooke's Hospital, Cambridge University Hospitals National Health Service Foundation Trust, Cambridge, GBR.

出版信息

Cureus. 2024 Aug 1;16(8):e65954. doi: 10.7759/cureus.65954. eCollection 2024 Aug.

DOI:10.7759/cureus.65954
PMID:39221371
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11365573/
Abstract

INTRODUCTION

Liver stiffness measurement (LSM) using vibration-controlled transient elastography (VCTE) is being increasingly used as a screening tool to predict varices. Our aim was to test the utility of Baveno VII criteria and other combinations of LSM, platelet count (PC), and splenic stiffness measurement (SSM) to predict the presence of varices in a cohort of Sri Lankan patients with compensated advanced liver cell disease (cALCD).

METHODS

Consecutive patients with newly diagnosed Child-Pugh class A cALCD (non-viral, BMI<30) were recruited prospectively. They underwent gastroscopy. LSM and SSM were taken using vibration-controlled transient elastography (VCTE) (Echosens FibroScan 502 Touch; Echosens SA, Paris, France) by a single operator who was unaware of endoscopy findings. Sensitivity, specificity, positive predictive value (PPV), negative predictive value (NPV), and accuracy of different Baveno VII criteria to predict the varices and different combinations of LSM, SSM, and PC were also explored.

RESULTS

One hundred and seventy-four individuals were recruited. The mean age was 61.4 ((95% CI: 59.7-62.8) years. A total of 110 individuals were males, and 106 had varices. Our results indicated that the three Baveno VII criteria had sensitivities of 61%, 63%, and 42%, and specificities of 79%, 77%, and 87% to predict varices. SSM>30kPa alone and in combination with LSM>15kPa had sensitivities of 81 and 75%, specificities of 72 and 83%, PPVs of 82 and 87%, NPVs of 71% and 67%, and accuracies of 78 and 78%, respectively, to predict varices.

CONCLUSION

Baveno VII criteria had a low sensitivity but high specificity in predicting the presence of varices. However, SSM>30kPa alone or in combination with LSM>15kPa had better sensitivity, specificity, PPV, NPV, and accuracy in predicting varices.

摘要

引言

使用振动控制瞬时弹性成像(VCTE)进行肝脏硬度测量(LSM)越来越多地被用作预测静脉曲张的筛查工具。我们的目的是测试巴韦诺 VII 标准以及 LSM、血小板计数(PC)和脾硬度测量(SSM)的其他组合在一组斯里兰卡代偿期晚期肝细胞疾病(cALCD)患者中预测静脉曲张存在的效用。

方法

前瞻性招募新诊断为 Child-Pugh A 级 cALCD(非病毒性,BMI<30)的连续患者。他们接受了胃镜检查。由一名不知道内镜检查结果的操作员使用振动控制瞬时弹性成像(VCTE)(Echosens FibroScan 502 Touch;Echosens SA,法国巴黎)进行 LSM 和 SSM 测量。还探讨了不同巴韦诺 VII 标准预测静脉曲张的敏感性、特异性、阳性预测值(PPV)、阴性预测值(NPV)和准确性,以及 LSM、SSM 和 PC 的不同组合。

结果

共招募了 174 名个体。平均年龄为 61.4((95%CI:59.7 - 62.8)岁。其中 110 名为男性,106 人有静脉曲张。我们的结果表明,三个巴韦诺 VII 标准预测静脉曲张的敏感性分别为 61%、63%和 42%,特异性分别为 79%、77%和 87%。单独的 SSM>30kPa 以及与 LSM>15kPa 联合使用时,预测静脉曲张的敏感性分别为 81%和 75%,特异性分别为 72%和 83%,PPV 分别为 82%和 87%,NPV 分别为 71%和 67%,准确性分别为 78%和 78%。

结论

巴韦诺 VII 标准在预测静脉曲张存在方面敏感性较低但特异性较高。然而,单独的 SSM>30kPa 或与 LSM>15kPa 联合使用在预测静脉曲张方面具有更好的敏感性、特异性、PPV、NPV 和准确性。